{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:05:33Z","timestamp":1783566333178,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04230-8","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T17:20:06Z","timestamp":1740849606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of circALPK2 enhances proliferation and therapeutic potential of human pluripotent stem cell-derived cardiomyocytes in myocardial infarction"],"prefix":"10.1186","volume":"16","author":[{"given":"Hongchun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-8429","authenticated-orcid":false,"given":"Shijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"8","key":"4230_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93\u2013621.","journal-title":"Circulation"},{"key":"4230_CR2","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.eclinm.2022.101530","volume":"50","author":"N Salerno","year":"2022","unstructured":"Salerno N, Salerno L, Marino F, Scalise M, Chiefalo A, Panuccio G, et al. Myocardial regeneration protocols towards the routine clinical scenario: an unseemly path from bench to bedside. EClinicalMedicine. 2022;50:101530.","journal-title":"EClinicalMedicine"},{"key":"4230_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yjmcc.2023.04.001","volume":"179","author":"I Secco","year":"2023","unstructured":"Secco I, Giacca M. Regulation of endogenous cardiomyocyte proliferation: the known unknowns. J Mol Cell Cardiol. 2023;179:80\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"4230_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.119.044484","volume":"142","author":"Y Li","year":"2020","unstructured":"Li Y, Feng J, Song S, Li H, Yang H, Zhou B, et al. gp130 controls cardiomyocyte proliferation and heart regeneration. Circulation. 2020;142(10):967\u201382.","journal-title":"Circulation"},{"issue":"4","key":"4230_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.stem.2022.03.009","volume":"29","author":"J Du","year":"2022","unstructured":"Du J, Zheng L, Gao P, Yang H, Yang WJ, Guo F, et al. A small-molecule cocktail promotes mammalian cardiomyocyte proliferation and heart regeneration. Cell Stem Cell. 2022;29(4):545\u201358. e13.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"4230_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","volume":"26","author":"A Oikonomopoulos","year":"2018","unstructured":"Oikonomopoulos A, Kitani T, Wu JC. Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: Progress and hurdles for clinical translation. Mol Ther. 2018;26(7):1624\u201334.","journal-title":"Mol Ther"},{"issue":"5","key":"4230_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-020-0816-0","volume":"115","author":"N Abbas","year":"2020","unstructured":"Abbas N, Perbellini F, Thum T. Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration. Basic Res Cardiol. 2020;115(5):52.","journal-title":"Basic Res Cardiol"},{"key":"4230_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.omtn.2020.01.013","volume":"19","author":"B Wang","year":"2020","unstructured":"Wang B, Xu M, Li M, Wu F, Hu S, Chen X, et al. miR-25 promotes Cardiomyocyte Proliferation by Targeting FBXW7. Mol Ther Nucleic Acids. 2020;19:1299\u2013308.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7429","key":"4230_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11739","volume":"492","author":"A Eulalio","year":"2012","unstructured":"Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012;492(7429):376\u201381.","journal-title":"Nature"},{"key":"4230_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijcard.2015.06.163","volume":"201","author":"D Liang","year":"2015","unstructured":"Liang D, Li J, Wu Y, Zhen L, Li C, Qi M, et al. miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2. Int J Cardiol. 2015;201:38\u201348.","journal-title":"Int J Cardiol"},{"issue":"12","key":"4230_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00109-017-1591-8","volume":"95","author":"M Arif","year":"2017","unstructured":"Arif M, Pandey R, Alam P, Jiang S, Sadayappan S, Paul A, et al. MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents. J Mol Med (Berl). 2017;95(12):1369\u201385.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"4230_CR12","doi-asserted-by":"publisher","first-page":"106593","DOI":"10.1016\/j.isci.2023.106593","volume":"26","author":"HV Renikunta","year":"2023","unstructured":"Renikunta HV, Lazarow K, Gong Y, Shukla PC, Nageswaran V, Giral H, et al. Large-scale microRNA functional high-throughput screening identifies mir-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation. iScience. 2023;26(5):106593.","journal-title":"iScience"},{"issue":"25","key":"4230_CR13","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of Super-enhancer-regulated circRNA Nfix induces Cardiac Regeneration after myocardial infarction in adult mice. Circulation. 2019;139(25):2857\u201376.","journal-title":"Circulation"},{"issue":"1","key":"4230_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41420-021-00467-3","volume":"7","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhao P, Sun L, Lu Y, Zhu W, Zhang J, et al. Overexpression of circRNA SNRK targets mir-103-3p to reduce apoptosis and promote cardiac repair through GSK3beta\/beta-catenin pathway in rats with myocardial infarction. Cell Death Discov. 2021;7(1):84.","journal-title":"Cell Death Discov"},{"key":"4230_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.omtn.2020.06.024","volume":"21","author":"X Si","year":"2020","unstructured":"Si X, Zheng H, Wei G, Li M, Li W, Wang H, et al. circRNA Hipk3 induces Cardiac Regeneration after myocardial infarction in mice by binding to Notch1 and miR-133a. Mol Ther Nucleic Acids. 2020;21:636\u201355.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"15","key":"4230_CR16","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1093\/cvr\/cvab335","volume":"118","author":"HJ Hunkler","year":"2022","unstructured":"Hunkler HJ, Gross S, Thum T, Bar C. Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration. Cardiovasc Res. 2022;118(15):3071\u201384.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4230_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13287-018-0793-5","volume":"9","author":"W Lei","year":"2018","unstructured":"Lei W, Feng T, Fang X, Yu Y, Yang J, Zhao ZA, et al. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. Stem Cell Res Ther. 2018;9(1):56.","journal-title":"Stem Cell Res Ther"},{"key":"4230_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.isci.2018.03.010","volume":"2","author":"P Hofsteen","year":"2018","unstructured":"Hofsteen P, Robitaille AM, Strash N, Palpant N, Moon RT, Pabon L, et al. ALPK2 promotes Cardiogenesis in zebrafish and human pluripotent stem cells. iScience. 2018;2:88\u2013100.","journal-title":"iScience"},{"issue":"6","key":"4230_CR19","doi-asserted-by":"publisher","first-page":"H1509","DOI":"10.1152\/ajpheart.00249.2020","volume":"318","author":"J Bogomolovas","year":"2020","unstructured":"Bogomolovas J, Feng W, Yu MD, Huang S, Zhang L, Trexler C, et al. Atypical ALPK2 kinase is not essential for cardiac development and function. Am J Physiol Heart Circ Physiol. 2020;318(6):H1509\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5391","key":"4230_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"1","key":"4230_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41392-024-01791-7","volume":"9","author":"X Han","year":"2024","unstructured":"Han X, Qu L, Yu M, Ye L, Shi L, Ye G, et al. Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity. Signal Transduct Target Ther. 2024;9(1):86.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4230_CR22","first-page":"18","volume":"10","author":"QY Guo","year":"2023","unstructured":"Guo QY, Yang JQ, Feng XX, Zhou YJ. Regeneration of the heart: from molecular mechanisms to clinical therapeutics. Mil Med Res. 2023;10(1):18.","journal-title":"Mil Med Res"},{"issue":"21","key":"4230_CR23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jacc.2021.09.019","volume":"78","author":"J Zhang","year":"2021","unstructured":"Zhang J, Bolli R, Garry DJ, Marban E, Menasche P, Zimmermann WH, et al. Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-art review. J Am Coll Cardiol. 2021;78(21):2092\u2013105.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4230_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 2018;15(10):585\u2013600.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"4230_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.120.049715","volume":"143","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Xia L, Fan S, Zheng J, Qin J, Fan X, et al. Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated smooth muscle cell differentiation. Circulation. 2021;143(4):354\u201371.","journal-title":"Circulation"},{"issue":"7","key":"4230_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","volume":"116","author":"H Li","year":"2020","unstructured":"Li H, Xu JD, Fang XH, Zhu JN, Yang J, Pan R, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and mir-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323\u201334.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"4230_CR27","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.ymthe.2022.06.016","volume":"30","author":"H Zheng","year":"2022","unstructured":"Zheng H, Huang S, Wei G, Sun Y, Li C, Si X, et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output. Mol Ther. 2022;30(11):3477\u201398.","journal-title":"Mol Ther"},{"issue":"3","key":"4230_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41418-021-00872-2","volume":"29","author":"XQ Gao","year":"2022","unstructured":"Gao XQ, Liu CY, Zhang YH, Wang YH, Zhou LY, Li XM, et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Differ. 2022;29(3):527\u201339.","journal-title":"Cell Death Differ"},{"issue":"23","key":"4230_CR29","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1073\/pnas.0702859104","volume":"104","author":"S Ueno","year":"2007","unstructured":"Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, et al. Biphasic role for Wnt\/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104(23):9685\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4230_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2020.06.001","volume":"27","author":"JW Buikema","year":"2020","unstructured":"Buikema JW, Lee S, Goodyer WR, Maas RG, Chirikian O, Li G, et al. Wnt activation and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-Derived cardiomyocytes. Cell Stem Cell. 2020;27(1):50\u201363. e5.","journal-title":"Cell Stem Cell"},{"key":"4230_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fncel.2013.00220","volume":"7","author":"M Coolen","year":"2013","unstructured":"Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci. 2013;7:220.","journal-title":"Front Cell Neurosci"},{"key":"4230_CR32","doi-asserted-by":"publisher","first-page":"109687","DOI":"10.1016\/j.biopha.2019.109687","volume":"122","author":"X Li","year":"2020","unstructured":"Li X, Zeng Z, Wang J, Wu Y, Chen W, Zheng L, et al. MicroRNA-9 and breast cancer. Biomed Pharmacother. 2020;122:109687.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4230_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/CIRCRESAHA.122.321770","volume":"132","author":"BN Singh","year":"2023","unstructured":"Singh BN, Yucel D, Garay BI, Tolkacheva EG, Kyba M, Perlingeiro RCR, et al. Proliferation and maturation: Janus and the art of Cardiac tissue Engineering. Circ Res. 2023;132(4):519\u201340.","journal-title":"Circ Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04230-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T17:20:08Z","timestamp":1740849608000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04230-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04230-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments involving human cells and animals were approved by the Ethics Committee of First Affiliated Hospital of Soochow University (No. 2022\u2009\u2212\u2009519; Project title: Effects of noncoding RNAs on the maturation and therapeutic potential of hPSC-derived cardiac cells in cardiovascular diseases; Date of approval: March 1, 2022). Human cardiac cells used in this study were differentiated in vitro from H1 hESCs, a human ESC line established following ethical approval and informed consent [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}